These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

673 related items for PubMed ID: 7998413

  • 21. Comparative study of the immunogenicity and safety of two dosing schedules of hepatitis B vaccine in neonates.
    Bassily S, Kotkat A, Gray G, Hyams KC, Brown FM, Imam IZ, Arthur R.
    Am J Trop Med Hyg; 1995 Oct; 53(4):419-22. PubMed ID: 7485697
    [Abstract] [Full Text] [Related]

  • 22. Hepatitis B vaccine alone may be enough for preventing hepatitis B virus transmission in neonates of HBsAg (+)/HBeAg (-) mothers.
    Lu Y, Liang XF, Wang FZ, Yan L, Li RC, Li YP, Zhu FC, Zhai XJ, Li J, Zhuang H.
    Vaccine; 2017 Jan 03; 35(1):40-45. PubMed ID: 27894717
    [Abstract] [Full Text] [Related]

  • 23. Prevention of perinatal transmission of hepatitis B virus (HBV) to children of e antigen-positive HBV carrier mothers by hepatitis B immune globulin and HBV vaccine.
    Kanai K, Takehiro A, Noto H, Nishida M, Takahashi K, Kawashima Y, Igarashi Y, Matsushita K, Shimizu M.
    J Infect Dis; 1985 Feb 03; 151(2):287-90. PubMed ID: 3155779
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Hepatitis B immunisation coverage of infants born to chronic carrier mothers in Victoria.
    Oman KM, Carnie J, Ruff T.
    Aust N Z J Public Health; 1997 Dec 03; 21(7):731-4. PubMed ID: 9489190
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Immunogenicity of recombinant hepatitis B vaccine: comparison of two different vaccination schedules.
    Agladioglu S, Beyazova U, Camurdan AD, Sahin F, Atak A.
    Infection; 2010 Aug 03; 38(4):269-73. PubMed ID: 20512395
    [Abstract] [Full Text] [Related]

  • 28. Hepatitis B immunization in high risk neonates born from HBsAg positive mothers: comparison between plasma derived and recombinant DNA vaccine.
    Pongpipat D, Suvatte V, Assateerawatts A.
    Asian Pac J Allergy Immunol; 1989 Jun 03; 7(1):37-40. PubMed ID: 2526633
    [Abstract] [Full Text] [Related]

  • 29. A program for eradication of hepatitis B from Taiwan by a 10-year, four-dose vaccination program.
    Chen DS, Hsu HM, Bennett CL, Pajeau TS, Blumberg B, Chang PY, Nishioka K, Huang A, Sung JL.
    Cancer Causes Control; 1996 May 03; 7(3):305-11. PubMed ID: 8734823
    [Abstract] [Full Text] [Related]

  • 30. Prevention of perinatal transmission of hepatitis B virus: a comparison between the efficacy of passive and passive-active immunization in Korea.
    Chung WK, Yoo JY, Sun HS, Lee HY, Lee IJ, Kim SM, Prince AM.
    J Infect Dis; 1985 Feb 03; 151(2):280-6. PubMed ID: 3155778
    [Abstract] [Full Text] [Related]

  • 31. A combination of hepatitis B vaccine and immunoglobulin does not protect all infants born to hepatitis B e antigen positive mothers.
    Farmer K, Gunn T, Woodfield DG.
    N Z Med J; 1987 Jul 08; 100(827):412-4. PubMed ID: 2967932
    [Abstract] [Full Text] [Related]

  • 32. Evaluation of a low dose of hepatitis B vaccine given within a childhood immunisation programme in Singapore.
    Oon CJ, Tan KL, Goh KT, Wong-Yong L, Viegas O, McCarthy T, Chan SH, Lee HP.
    J Infect; 1986 Nov 08; 13(3):255-67. PubMed ID: 2947953
    [Abstract] [Full Text] [Related]

  • 33. [Efficacy of recombinant hepatitis B vaccine and low-dose hepatitis B immune globulin in preventing mother-infant transmission of hepatitis B virus infection].
    Xia GL, Gong J, Wang JJ, Meng ZD, Jia ZY, Cao HL, Liu CB.
    Zhonghua Liu Xing Bing Xue Za Zhi; 2003 May 08; 24(5):362-5. PubMed ID: 12820927
    [Abstract] [Full Text] [Related]

  • 34. Combined passive and active immunization for interruption of perinatal transmission of hepatitis B virus in Taiwan.
    Lo KJ, Tsai YT, Lee SD, Yeh CL, Wang JY, Chiang BN, Wu TC, Yeh PS, Goudeau A, Coursaget P.
    Hepatogastroenterology; 1985 Apr 08; 32(2):65-8. PubMed ID: 3159639
    [Abstract] [Full Text] [Related]

  • 35. The first five years of universal hepatitis B vaccination in South Africa: evidence for elimination of HBsAg carriage in under 5-year-olds.
    Tsebe KV, Burnett RJ, Hlungwani NP, Sibara MM, Venter PA, Mphahlele MJ.
    Vaccine; 2001 Jul 16; 19(28-29):3919-26. PubMed ID: 11427266
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. [Immunogenicity and harmlessness in the newborn of a vaccine (GenHevac B) containing the antigens S and pre-S2].
    Tron F, Soulié JC, Goudeau A, Devillier P, Saliou P.
    Bull Soc Pathol Exot; 1991 Jul 16; 84(5 Pt 5):901-5. PubMed ID: 1840243
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Protective effect of hepatitis B vaccine combined with two-dose hepatitis B immunoglobulin on infants born to HBsAg-positive mothers.
    Zou H, Chen Y, Duan Z, Zhang H.
    PLoS One; 2011 Jul 16; 6(10):e26748. PubMed ID: 22053208
    [Abstract] [Full Text] [Related]

  • 40. The efficacy of two different dosages of hepatitis B immunoglobulin combined with hepatitis B vaccine in preventing mother-to-child transmission of hepatitis B virus: A prospective cohort study.
    Wei KP, Zhu FC, Liu JX, Yan L, Lu Y, Zhai XJ, Chang ZJ, Zeng Y, Li J, Zhuang H.
    Vaccine; 2018 Jan 04; 36(2):256-263. PubMed ID: 29195717
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 34.